Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoxia-Inducible Factor-1alpha/BNIP3-Mediated Mitochondrial Autophagy in Septic Cardiomyopathy: Protective Mechanism for Cardiac Function.

Physiological research·2026
Same author

Observation of In-Ice Askaryan Radiation from High-Energy Cosmic Rays.

Physical review letters·2026
Same author

Efficient and High-Fidelity Entanglement in Cavity QED without High Cooperativity.

Physical review letters·2026
Same author

Prognostic score models for acquired resistance to frontline anti-programmed cell death protein 1/programmed death-ligand 1 therapy in metastatic non-small-cell lung cancer.

ESMO real world data and digital oncology·2026
Same author

Temporal and Notch identity determine neuropil targeting depth and synapse location in the fly visual system.

bioRxiv : the preprint server for biology·2025
Same author

Ventilation or aerosol extraction: comparing the efficacy of directional air purifiers, HEPA evacuators and negative-pressure environments.

The Journal of hospital infection·2024

Related Experiment Videos

Whole-body vibration for functional constipation: a single-centre, single-blinded, randomized controlled trial.

T-J Wu1, T-S Wei, Y-H Chou

  • 1Department of Physical Medicine and Rehabilitation, Changhua Christian Hospital, Changhua, Taiwan.

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|September 13, 2012
PubMed
Summary

Whole-body vibration (WBV) therapy shows promise for chronic functional constipation by reducing symptom severity. This noninvasive treatment improved constipation severity scores but did not impact quality of life in the study.

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Physical Therapy

Background:

  • Chronic functional constipation affects a significant portion of the population.
  • Current treatments for chronic functional constipation have limitations.
  • Noninvasive therapies are sought to improve patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of whole-body vibration (WBV) therapy for chronic functional constipation.
  • To assess the impact of WBV on constipation severity and health-related quality of life (HRQOL).

Main Methods:

  • A single-blinded, randomized controlled trial was conducted.
  • Patients with chronic functional constipation received either WBV therapy or no treatment for two weeks.
  • Constipation symptoms were assessed using the Constipation Severity Instrument (CSI).

Main Results:

  • WBV therapy significantly reduced overall CSI scores and obstructive defecation subscale scores.
  • No significant improvement was observed in pain or chronic inertia subscale scores.
  • Health-related quality of life (HRQOL) did not improve with WBV treatment.

Conclusions:

  • Low-intensity WBV therapy may be an effective treatment for reducing symptom severity in chronic functional constipation.
  • Further research is needed to explore WBV's effects on other constipation-related symptoms and HRQOL.
  • Noninvasive oscillation platforms offer a potential therapeutic option for managing constipation.